{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-256103","form_type":"8-K","ticker":"MIRM","cik":"0001759425","company_name":"Mirum Pharmaceuticals, Inc.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.336691+00:00","generated_at":"2026-06-10T00:06:36.533362+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Mirum files updated risk factor disclosure; no financial or operational news","bullets":["Update includes risks related to sole-source contract manufacturers for commercial supplies.","Lists risk of needing additional financing for commercialization and product development.","Notes potential delays in patient enrollment and clinical trial completion.","References the Asset Purchase and risk of not realizing its anticipated benefits."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-256103","json":"https://secwatch.observer/filing/0001193125-23-256103.json","markdown":"https://secwatch.observer/filing/0001193125-23-256103.md","text":"https://secwatch.observer/filing/0001193125-23-256103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759425/000119312523256103/0001193125-23-256103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759425/000119312523256103/d424554d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:06:36.533362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}